Rafael Holdings, Inc. completed the restructuring of its debt and equity interests in Cornerstone Pharmaceuticals, Inc., resulting in Rafael Holdings indirectly holding certain debt interests and owning or controlling approximately 67.03% of Cornerstone's outstanding equity.